1. Home
  2. CDLX vs BMRA Comparison

CDLX vs BMRA Comparison

Compare CDLX & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

N/A

Current Price

$1.34

Market Cap

10.1M

Sector

Technology

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$1.35

Market Cap

8.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDLX
BMRA
Founded
2008
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
8.5M
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
CDLX
BMRA
Price
$1.34
$1.35
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $4.43
N/A
AVG Volume (30 Days)
★ 67.3K
9.8K
Earning Date
11-05-2026
10-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 50.13
39.81
EPS
N/A
★ N/A
Revenue
★ $233,273,000.00
$4,453,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.53
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.55
$1.27
52 Week High
$6.40
$2.94

Technical Indicators

Market Signals
Indicator
CDLX
BMRA
Relative Strength Index (RSI) 28.35 28.69
Support Level $0.85 N/A
Resistance Level $2.32 $1.75
Average True Range (ATR) 0.20 0.12
MACD -0.00 -0.03
Stochastic Oscillator 2.02 15.38

Price Performance

Historical Comparison
CDLX
BMRA

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.

Share on Social Networks: